Verastem, Inc. — Director's Dealing 2017

Oct 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2017-10-09

Reporting Person: Le NgocDiep T. MD, PhD (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-09	Stock Option (Right to Buy)	$4.63	A	300000	Acquired	2027-10-09	Common Stock (300000)	Direct

Footnotes

F1: 25% of this option will vest on October 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until October 9, 2021.